Total Payments
$616,024
2024 Payments
$20,580
Companies
46
Transactions
1,227
Medicare Patients
1,664
Medicare Billing
$324,675
Payment Breakdown by Category
Other$411,196 (66.8%)
Consulting$108,458 (17.6%)
Travel$75,403 (12.2%)
Food & Beverage$20,639 (3.4%)
Education$327.64 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $411,196 | 166 | 66.8% |
| Consulting Fee | $108,458 | 38 | 17.6% |
| Travel and Lodging | $75,403 | 291 | 12.2% |
| Food and Beverage | $20,639 | 724 | 3.4% |
| Education | $327.64 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $395,337 | 478 | $0 (2024) |
| EMD Serono, Inc. | $97,621 | 168 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $48,936 | 78 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $47,002 | 96 | $0 (2019) |
| Allergan, Inc. | $11,334 | 48 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $3,401 | 18 | $0 (2017) |
| Mallinckrodt LLC | $3,034 | 22 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $2,485 | 8 | $0 (2024) |
| Celgene Corporation | $1,420 | 11 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,141 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,580 | 27 | EMD Serono, Inc. ($20,209) |
| 2023 | $27,356 | 48 | EMD Serono, Inc. ($23,412) |
| 2022 | $6,200 | 21 | Alexion Pharmaceuticals, Inc. ($5,777) |
| 2021 | $6,089 | 27 | Alexion Pharmaceuticals, Inc. ($3,967) |
| 2020 | $22,245 | 47 | EMD Serono, Inc. ($13,339) |
| 2019 | $71,519 | 118 | Alexion Pharmaceuticals, Inc. ($33,046) |
| 2018 | $189,541 | 275 | GENZYME CORPORATION ($159,126) |
| 2017 | $272,495 | 664 | GENZYME CORPORATION ($227,832) |
All Payment Transactions
1,227 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $134.82 | General |
| 11/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $102.50 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Neurology | ||||||
| 10/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $34.76 | General |
| 10/09/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.73 | General |
| 09/25/2024 | Biogen, Inc. | TECFIDERA (Drug), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Neurology | ||||||
| 08/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Rare Disease | ||||||
| 08/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $40.85 | General |
| 07/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Immunology | ||||||
| 07/09/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.33 | General |
| 06/24/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.10 | General |
| 06/24/2024 | EMD Serono, Inc. | — | Education | In-kind items and services | $12.56 | General |
| 06/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Neurology | ||||||
| 05/28/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $76.20 | General |
| Category: Neuroscience | ||||||
| 05/08/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $36.23 | General |
| 04/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $34.99 | General |
| Category: Neuroscience | ||||||
| 03/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $36.67 | General |
| 03/12/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Neurology | ||||||
| 02/21/2024 | GENZYME CORPORATION | AUBAGIO (Drug), LEMTRADA | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Neurology | ||||||
| 02/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.77 | General |
| 01/09/2024 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $73.43 | General |
| 01/09/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| 01/04/2024 | EMD Serono, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,843.00 | General |
| 01/04/2024 | EMD Serono, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| 01/02/2024 | EMD Serono, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 287 | 11,383 | $213,457 | $74,588 |
| 2022 | 8 | 366 | 9,864 | $222,575 | $74,380 |
| 2021 | 9 | 469 | 11,009 | $327,414 | $90,513 |
| 2020 | 10 | 542 | 9,678 | $352,541 | $85,194 |
Total Patients
1,664
Total Services
41,934
Medicare Billing
$324,675
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 17 | 11,000 | $94,428 | $41,918 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 201 | $58,415 | $16,798 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 59 | $23,039 | $7,256 | 31.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 15 | 48 | $24,768 | $4,548 | 18.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $8,928 | $2,716 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 17 | $3,417 | $1,025 | 30.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 30 | 42 | $462.00 | $328.19 | 71.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 15 | 9,400 | $83,448 | $36,723 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 230 | $66,930 | $18,292 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 61 | 71 | $27,832 | $8,760 | 31.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 13 | 40 | $20,640 | $4,126 | 20.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $14,508 | $3,669 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,851 | $1,414 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 18 | $3,618 | $1,196 | 33.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 47 | 68 | $748.00 | $198.45 | 26.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 14 | 10,200 | $148,548 | $40,358 | 27.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 219 | 301 | $87,591 | $25,171 | 28.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 66 | 73 | $28,616 | $9,016 | 31.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 55 | 55 | $30,690 | $8,956 | 29.2% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 12 | 43 | $22,188 | $4,760 | 21.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $8,379 | $1,939 | 23.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 62 | 96 | $1,056 | $283.00 | 26.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 11 | 62 | $186.00 | $16.71 | 9.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 11 | 160 | $160.00 | $12.67 | 7.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 18 | 9,000 | $148,000 | $34,729 | 23.5% |
About Dr. David Meyer, MD
Dr. David Meyer, MD is a Neurology healthcare provider based in Winston-Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205879558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Meyer, MD has received a total of $616,024 in payments from pharmaceutical and medical device companies, with $20,580 received in 2024. These payments were reported across 1,227 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($411,196).
As a Medicare-enrolled provider, Meyer has provided services to 1,664 Medicare beneficiaries, totaling 41,934 services with total Medicare billing of $324,675. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Winston-Salem, NC
- Active Since 06/14/2006
- Last Updated 03/04/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1205879558
Products in Payments
- LEMTRADA (Drug) $204,085
- AUBAGIO (Drug) $187,043
- COPAXONE (Drug) $33,948
- Mavenclad (Biological) $20,610
- Rebif (Biological) $18,931
- VRAYLAR (Drug) $10,018
- Mavenclad (Drug) $8,953
- Evobrutinib $6,600
- SD809-TD (Drug) $5,617
- Rebif (Drug) $4,386
- DISEASE STATE (Drug) $4,089
- AJOVY (Drug) $3,499
- ONZETRA Xsail (Drug) $3,339
- ACTHAR (Biological) $3,034
- ULTOMIRIS (Biological) $1,699
- UBRELVY (Drug) $1,150
- LATUDA (Drug) $1,050
- TYSABRI (Biological) $463.14
- KESIMPTA (Drug) $371.91
- ZEPOSIA (Drug) $369.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.